Navigation Links
Palatin Technologies to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Date:11/2/2007

CRANBURY, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (Amex: PTN) today announced that it will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference at the New York Palace Hotel in New York on Monday, November 5, 2007 at 4:45 PM ET.

Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on the Company's corporate and development programs. To access the live audio broadcast or the subsequent archived recording, log onto http://www.palatin.com.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Researchers Develop Technologies to Devour Food Pathogens
2. Researchers Study Safety of Assisted Reproductive Technologies
3. India to Propose Global Fund for Clean Energy Technologies
4. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
5. Researchers Present Ways To Reduce The Risk Of Dementia
6. Researchers Present Data Regarding The Efficiency Of Herbs
7. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
8. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
9. Drug Reactions First Present Themselves In The Mouth
10. Reminiscing Into The Past Makes You Dissatisfied With The Present
11. Living In The Past Indicates Dissatisfaction With Present
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...Jan. 8 The Alliance for...poses the new marketing campaigns by Wal-Mart, Sto...vide free prescribed antibiotics to customers. The...ll actually lead to increased costs in the form of...ce. While the public,s need for affordable health...
(Date:1/8/2009)...Jan. 8 A study released this week ...fering from multiple chronic diseases shines a muc...ealth care system to one that focuses on primary a...ive Medicine, the leader in disease prevention. ...h/20080506/NETU129LOGO ) , , The study, condu...
(Date:1/8/2009)...ia Assembly Member Tom Torlakson Introduces AB 89 ...wswire/ -- Today, Lung Cancer Alliance-Californi...Torlakson (D-11th District) for his continued lead...g for lung cancer research. For the third consecu... research is being considered in the California Le...
(Date:1/8/2009)...quick to condemn hurtful comments, study suggests ...- Many people overestimate how strongly they would... , Sixty-three percent of study participants at...er for an experiment with a white person rather th...acist comments about the black person when he left...
Breaking Medicine News(10 mins):Health News:Antibiotics as Loss Leaders? 2Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Many Turn Blind Eye to Racism 2
...en from 55 countries who will be the fourth Intern... four-day international congress titled "WWH-2005"...st time in South Asia. The earlier meetings were h...de Janeiro (1999) and Stockholm (2002). Among its ...
...sing the cholesterol level in blood.High level of ... in moderate amounts, can lead to serious health r...n of University College London examined 199 health...how individuals react to stress and whether their ...
...s have successfully treated nerve damage in mice b...stem cells, and hope to treat patients with an inj...n future.// The results of the new research sugges...ervous axon growth and functional recovery after n...
..., the families of more than 1,200 children, whose ...nts' knowledge ,will each receive Compensations.//...eal announced recently ,in the United Kingdom. Th...ht the cases involving organ-retention at 146 hosp...
Other Medicine News:Health News:Delhi To Host International Women’s Congress From Nov 2 2Health News:Stem Cells From Hair Follicle To Repair Nerve Damage 2Health News:Organ Scandals Compensation And The Aftermath 2
(Date:1/6/2009)...e-FirstCall/ -- , - Early Renewal of the Ag...r 2011 , - Expansion of the Scope of the Co...halmology , - Revised Commercial Terms and ...Third Party , ExonHit Therapeutics (Alter...ts existing drug discovery collaboration with Alle...
(Date:1/5/2009)...irstCall/ -- Micromet, Inc.,(Nasdaq: MITI ), a ...etary,antibodies for the treatment of cancer, inf...tlook on key events anticipated for the year 2009....on its research and development,programs at the f... Update on several preclinical BiTE antibodies at,...
(Date:1/3/2009)...ll., Jan. 2 Magnetic re...iding an increasing number of clinical benefits wh...o an article in the January 2009 issue of the Jour...s ( http://www.jaaos.org/ ). It is predicted that... developments will allow MRI to provide even more ...
(Date:12/29/2008)...wswire/ -- The winner of the 2008 Award for Excell...day by Dr. Peter G. Goldschmidt, President and Fou...The winner of the annual award was the Universi...its best practice " IND Regulatory and Monitoring ...uman subjects protection, 2) improved data quality...
Breaking Medicine Technology:ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 32008 Human Research Protection Award Recipients Announced 2Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 1Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 2Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 3Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 4Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 5Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 6Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 7Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 8Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 9Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 10Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 11Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 12Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 13Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 14Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 15Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 16Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 17Medical Mutual of Ohio CareWorks Build a Healthier Workforce 18882 1Medical Mutual of Ohio CareWorks Build a Healthier Workforce 18882 2Stereotaxis Market Leadership Highlighted at Heart Rhythm 2008 5257 1Stereotaxis Market Leadership Highlighted at Heart Rhythm 2008 5257 2Stereotaxis Market Leadership Highlighted at Heart Rhythm 2008 5257 3Stereotaxis Market Leadership Highlighted at Heart Rhythm 2008 5257 4Stereotaxis Market Leadership Highlighted at Heart Rhythm 2008 5257 5SemBioSys announces first quarter 2008 financial and operational results 5255 1SemBioSys announces first quarter 2008 financial and operational results 5255 2SemBioSys announces first quarter 2008 financial and operational results 5255 3SemBioSys announces first quarter 2008 financial and operational results 5255 4SemBioSys announces first quarter 2008 financial and operational results 5255 5SemBioSys announces first quarter 2008 financial and operational results 5255 6SemBioSys announces first quarter 2008 financial and operational results 5255 7SemBioSys announces first quarter 2008 financial and operational results 5255 8SemBioSys announces first quarter 2008 financial and operational results 5255 9SemBioSys announces first quarter 2008 financial and operational results 5255 10SemBioSys announces first quarter 2008 financial and operational results 5255 11SemBioSys announces first quarter 2008 financial and operational results 5255 12
...INESS WIRE)--May 9, 2007 - Regeneron,Pharmaceutica...esults from several studies evaluating the VEGF Tr...lar degeneration (wet AMD) and,diabetic macular ed... at the annual meeting of the Association for Rese...reported at the meeting,from a pre-planned interim...
...RE)--May 9, 2007 - Results of a Phase 2a,clinical ...d,amikacin) to treat hospital acquired gram-negati...erican Thoracic Society (ATS),International Confer... Dr. Michael S. Niederman, MD, Chairman, Depar...Hospital, Professor of, Medicine; Vice C...
Other Medicine Technology:VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 2VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 3VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 4VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 5Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 2Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 3
...LY-CLARK CLOtest Rapid Urease Test is recognized b...g urease tests because of its accuracy, convenienc...y Marshall, MD. who, along with Robin Warren, M.D.... H. pylori and gastric ulcers. Today, CLOtest has ...
Serim PyloriTek Test Kit detects urease activity in gastric biopsy specimens for the presumptive identification of an Helicobacter pylori infection.
...ickVue H.pylori gII test is a lateral-flow immuno-...itative detection of IgG antibodies specific to He...blood. It utilizes a convenient, non-invasive, and...s in the diagnosis of H.pylori infection in patien...
...re HP is a visually read, qualitative immunochroma... to H. pylori, a bacterium that grows in the stoma... some gastric cancers. FlexSure HP, available for ...ides the physician with the opportunity to perform...
Medicine Products: